AI assistant
Zymeworks Inc. — Director's Dealing 2026
Jan 13, 2026
32180_dirs_2026-01-13_a1f7337e-235a-4aab-b37c-315701585833.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Zymeworks Inc. (ZYME)
CIK: 0001937653
Period of Report: 2026-01-09
Reporting Person: Hollywood Mark (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 121367 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $15.23 | 2029-03-26 | Common Stock (80000) | Direct | |
| Stock Option (Right to Buy) | $35.20 | 2030-03-09 | Common Stock (24375) | Direct | |
| Stock Option (Right to Buy) | $34.82 | 2031-03-09 | Common Stock (30000) | Direct | |
| Stock Option (Right to Buy) | $7.00 | 2032-03-09 | Common Stock (90000) | Direct | |
| Stock Option (Right to Buy) | $8.00 | 2033-01-04 | Common Stock (61000) | Direct | |
| Stock Option (Right to Buy) | $10.56 | 2034-01-04 | Common Stock (90000) | Direct | |
| Stock Option (Right to Buy) | $13.22 | 2035-01-09 | Common Stock (79000) | Direct | |
| Restricted Stock Unit | $ | Common Stock (20000) | Direct | ||
| Restricted Stock Unit | $ | Common Stock (53000) | Direct |
Footnotes
F1: Stock option granted March 27, 2019.
F2: Stock options vest as follows: (i) 25% of underlying shares of common stock on first anniversary of grant date and (ii) remainder of underlying shares of common stock in 36 equal monthly installments on last day of month following first anniversary of grant date.
F3: Stock option granted March 10, 2020.
F4: Stock option granted March 10, 2021.
F5: Stock option granted March 10, 2022.
F6: Stock option granted January 5, 2023.
F7: Stock option granted January 5, 2024.
F8: Stock option granted January 10, 2025.
F9: 60,000 restricted stock units ("RSUs") granted January 5, 2024; vest in three equal annual installments beginning January 5, 2025. As of January 9, 2026, 20,000 RSUs remain outstanding.
F10: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of common stock.
F11: 53,000 restricted stock units ("RSUs") granted January 10, 2025; vest in three equal annual installments beginning January 10, 2026. As of January 9, 2026, 53,000 RSUs remain outstanding.